Neoadjuvant anti-programmed cell death 1 therapy for locally advanced basal cell carcinoma in treatment-naive patients: A case series.

Ligtenberg, Katherine Given; Hu, Jamie Katy; Damsky, William; Olino, Kelly; Kluger, Harriet; Clune, James; Cowper, Shawn E; Panse, Gauri; Leventhal, Jonathan; Weiss, Sarah A

Ligtenberg, Katherine Given; Hu, Jamie Katy; Damsky, William; Olino, Kelly; Kluger, Harriet; Clune, James; Cowper, Shawn E; Panse, Gauri; Leventhal, Jonathan; Weiss, Sarah A.

Afiliación

Ligtenberg KG; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Hu JK; Yale University School of Medicine, New Haven, Connecticut.
Damsky W; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Olino K; Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.
Kluger H; Department of Medicine/Medical Oncology, Yale University School of Medicine, New Haven, Connecticut.
Clune J; Department of Plastic and Reconstructive Surgery, Yale University School of Medicine, New Haven, Connecticut.
Cowper SE; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Panse G; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.
Leventhal J; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Weiss SA; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.

JAAD Case Rep ; 6(7): 628-633, 2020 Jul.

Article en En | MEDLINE | ID: mdl-32613057

Palabras clave

BCC, basal cell carcinoma; PD-1, antiprogrammed cell death 1; PD-L1, programmed cell death ligand 1; advanced basal cell carcinoma; antiPD-1; immunotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JAAD Case Rep Año: 2020 Tipo del documento: Article